key: cord-0919241-plnukt32 authors: Senapati, S.; Kshatri, J. S.; Prasad, P.; Turuk, J.; Pati, S.; Parida, A. title: A pilot study to investigate the fecal dissemination of SARS-CoV-2 virus genome in COVID-19 patients in Odisha, India date: 2020-05-29 journal: nan DOI: 10.1101/2020.05.26.20113167 sha: 8e050a4a184582f2bf37e750ad65b08be3d0b3c1 doc_id: 919241 cord_uid: plnukt32 In infectious diseases, the routes of transmission play major roles in determining the rate and extent of disease spread. Though fomites and aerosol droplets are major sources of SARS-CoV-2 human to human transmission, studies have also reported possible involvement of other routes of transmission like fecal-oral. Multiple studies around the world have reported shedding of the SARS-CoV-2 viral genome in certain COVID-19 patient fecal samples. Hence, the major objective of this study was to get the experimental evidence whether in Indian COVID-19 patients fecal dissemination of the SARS-CoV-2 genome occurs or not. Information obtained from twelve number of patients from a COVID-19 hospital of Odisha has demonstrated that both symptomatic and asymptomatic Indian patients could be positive for the SARS-CoV-2 genome in their fecal component. The findings have also established a protocol to collect and extract viral RNA for SARS-CoV-2 detection in fecal samples. Together, the study supports the hypothesis of possible fecal-oral transmission of SARS-CoV-2 virus and provides a rationale to extend this study in a larger cohort of patient samples and correlate the significance of the SARS-CoV-2 virus genome detection in fecal samples with disease severity and transmission. Recently, the novel severe acute respiratory syndrome coronavirus, SARS-CoV-2 has spread across the globe, including all states of India. The most common human-to-human transmission mode for this virus is through fomites, physical contact, aerosol droplets, nosocomial To date, the rate of COVID-19 spreading in India has not reached the predicted growth rate. Despite a large population size and improper hygienic practices, India have reported lesser incidence of infection compared with the western countries. A high proportion of asymptomatic cases and less mortality rate in the Indian population is also a striking difference compared with the other countries. These observations have provided an impetus for scientific communities to propose multiple hypotheses that might be playing roles in the aforementioned . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted May 29, 2020. . https://doi.org/10.1101/2020.05.26.20113167 doi: medRxiv preprint differential manifestation of COVID-19. It has been proposed that the genetic and immune makeup of the different human populations, environmental conditions, human-associated microbiota, food habits, etc. might be contributing to the spread and severity of this disease (Butler and Barrientos, 2020; Cao et al., 2020; Dhar and Mohanty, 2020; Wigginton and Boehm, 2020). It is also possible that all these factors might regulate the incidence of fecal shedding/ dissemination of infectious SARS-CoV-2 virus or its genome in the Indian population. Based on these observations, a pilot study was conucted to get an insight, whether fecal dissemination of the SARS-CoV2 genome also happens in the Indian population? . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted May 29, 2020. . https://doi.org/10.1101/2020.05.26.20113167 doi: medRxiv preprint The study was approved by the Institutional human ethical committee, ILS, Bhubaneswar, and the Govt. of Odisha, India. Informed consent was obtained from all the patients who participated in this study. All the samples used in this study were collected from patients admitted to a COVID-19 hospital, Odisha. Before hospitalization, all patients were tested positive for SARS-CoV-2 RNA in nasopharyngeal swab specimens through real-time reverse polymerase chain reaction (RT-qPCR). The initial diagnosis was done by COVID-19 testing centers approved by the Indian Council of Medical Research (ICMR) at Odisha. Details of patient information including clinical data were obtained from the hospitals are listed in Table 1 . The rectal swab (RS) and corresponding nasopharyngeal (NPS) swab for all the patients were collected on the same day by an experienced clinician of the COVID-19 hospital. The sterile swabs were used to collect samples from rectum and nasopharyngeal in 3 ml of DNA/RNA shield buffer (Zymo Research) and 3 ml of the virus transport medium (VTM) (HiMedia) respectively. As per the product information sheet, the DNA/RNA shield buffer inactivates infectious agents including virus and also stabilize DNA/RNA in the samples. All the samples were transported and stored at 4C. For viral RNA isolation, the samples were processed at BSL3 facility of ILS, Bhubaneswar, a recognized COVID-19 testing center. Viral RNA from RS and NPS samples was isolated using QIAamp Viral RNA Mini Kit (Qiagen). Before RNA isolation, MS2 phage control 10 µl from TaqPath™ COVID-19 multiplex real-time PCR diagnostic kit (Thermo Fisher Scientific) was added to the lysis buffer from QIAamp kit. MS2 phage control acts as an internal control for RNA isolation protocol. For isolation of RNA from RS samples, we optimized the protocol and all the samples were processed identically. Initially, . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 29, 2020. . https://doi.org/10.1101/2020.05.26.20113167 doi: medRxiv preprint all the samples were centrifuged for 5 min at 4000*g, and then 1.5 ml of the RS suspension were passed through a 0.22 micron filter. For each sample, 280 μl of the filtrate were processed for RNA isolation as per the QIAamp protocol. To isolate viral RNA from NPS, 140 μl of VTM from 3 ml was used for each sample. RNA elution for each sample was done with 50 μl of EB (Qiagen). The RT-qPCR assay was conducted following the current protocol followed by ILS for COVID-19 screening. TaqPath™ COVID-19 multiplex real-time PCR diagnostic kit (Thermo . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 29, 2020. . https://doi.org/10.1101/2020.05.26.20113167 doi: medRxiv preprint In RT-qPCR based disease diagnosis, the stability of DNA or RNA is a crucial point to avoid false-negative results. In our protocol to isolate RNA from rectal swab samples, we use DNA/RNA shield buffer, which confirms the suitability of this reagent for the collection of biological samples for SARS-CoV-2 genome detection and stability of RNA. The use of this reagent might also inactivate infectious agents and thus reduce the risk of exposure to infectious viral particles during handling. The RT-qPCR data analysis from 12 RS and corresponding NPS samples showed amplification of SARS-CoV2 RNA in six stool samples and eleven NPS samples. The amplification curve and the Ct values for different genes are presented in Figure 1 . Six samples from RS have Ct values that were not dertermined (ND), which may be due to low sample input or actual absence of viral genome in these samples. The corresponding NPS samples showed very high amplification curves (Fig 1 left panel) . The positive and negative control reactions showed amplification was as expected (data not shown). Based on the available clinical data, since the time of first SARS-CoV2 detection to the time of sample collection, seven patients were symptomatic and five were asymptomatic (Table 1 ). Four out of 5 (80%) asymptomatic and 2 out of 7 (28%) symptomatic cases were tested positive for the presence of viral genome in the rectal swab samples, respectively. The summary of clinical symptoms and the medical history of all the patients are shown in Table 1 . One patient (COVID19/GNG03) was found negative for both NPS and rectal swab samples, which indicates that the patient might have recovered from the disease during the period of hospitalizaion . . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 29, 2020. . https://doi.org/10.1101/2020.05.26.20113167 doi: medRxiv preprint To best of our knowledge this pilot study is the first report that confirms that in the eastern Indian COVID-19 patients, fecal dissemination of the SARS-CoV-2 genome is evident. The study is a part of the research activities conducted by the Odisha COVOD-19 study group. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 29, 2020. . https://doi.org/10.1101/2020.05.26.20113167 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 29, 2020. . https://doi.org/10.1101/2020.05.26.20113167 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 29, 2020. . https://doi.org/10.1101/2020.05.26.20113167 doi: medRxiv preprint Rectal Swab Figure 1 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted May 29, 2020. . https://doi.org/10.1101/2020.05.26.20113167 doi: medRxiv preprint Proton pump inhibitors and dysbiosis: Current knowledge and aspects to be clarified The impact of nutrition on COVID-19 susceptibility and long-term consequences Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations SARS-CoV-2-Positive Sputum and Feces After Conversion of Pharyngeal Samples in Patients With COVID-19 The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients Gut microbiota and Covid-19-possible link and implications COVID-19: Gastrointestinal Manifestations and Potential Fecal-Oral Transmission COVID-19 faecal-oral transmission: Are we asking the right questions? Diarrhoea may be underestimated: a missing link in 2019 novel coronavirus Association Between Acute Gastroenteritis and Continuous Use of Proton Pump Inhibitors During Winter Periods of Highest Circulation of Enteric Viruses Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted Environmental Engineers and Scientists Have Important Roles to Play in Stemming Outbreaks and Pandemics Caused by Enveloped Viruses Prolonged presence of SARS-CoV-2 viral RNA in faecal samples Evidence for Gastrointestinal Infection of SARS-CoV-2 TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes